Igor Bilinsky

Affiliations

  • Chief Operating Officer at Iovance Biotherapeutics Inc. (IOVA), 2024-04-17
  • Chief Business Officer at Oncternal Therapeutics Inc. (ONCT), 2021-02-16
  • Chief Operating Officer at Ampliphi Biosciences Corp (APHB), 2017-06-01
  • Gm, Immuno-Oncology/Svp Sp Ops at Ignyta Inc. (RXDX), 2016-01-11
  • Sr Vp, Corporate Development at Vical Inc (VICL), 2015-07-15
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
VICL $1.42 90,000 Officer 145,692 2014-01-10 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
VICL $0.70 1,258 Officer 193,798 2015-07-13 Filing
VICL $0.93 1,257 Officer 195,056 2015-04-13 Filing
VICL $1.16 1,335 Officer 126,313 2015-01-12 Filing
VICL $1.08 1,335 Officer 127,648 2014-10-13 Filing
VICL $1.25 12,500 Officer 128,983 2014-08-26 Filing